Azimut and SOQUEM Report Excellent Lithium Recoveries and Grades for Metallurgical Test Samples, Galinée Property, Quebec
October 17, 2024 06:30 ET
|
Exploration Azimut Inc
LONGUEIL, Quebec, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) is pleased to report excellent preliminary metallurgical test results for three...
LeddarTech annonce la réception de 3,0 millions de dollars américains à la suite du décaissement de la seconde tranche du financement relais annoncé précédemment
October 15, 2024 17:53 ET
|
LEDDARTECH HOLDINGS INC.
QUÉBEC, Canada, 15 oct. 2024 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (« LeddarTech » ou la « Société ») (NASDAQ : LDTC), une société de logiciels automobiles qui fournit des technologies...
LeddarTech Announces Receipt of US$3.0 Million Following Disbursement of the Second Tranche of the Previously Announced Bridge Financing
October 15, 2024 17:53 ET
|
LEDDARTECH HOLDINGS INC.
QUEBEC CITY, Canada, Oct. 15, 2024 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech” or the “Company”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive...
Azimut and SOQUEM Uncover Extensive Lithium Targets on the Galinée Property, James Bay region, Quebec
October 10, 2024 06:30 ET
|
Exploration Azimut Inc
LONGUEUIL, Quebec, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to announce that the 2024 field exploration program has...
Le CQDM et Epitopea financent le développement et la validation de CryptoMap™, une plateforme facilitant la création d'immunothérapies à base d'ARN
September 26, 2024 07:30 ET
|
Epitopea
MONTRÉAL, 26 sept. 2024 (GLOBE NEWSWIRE) -- Epitopea, une société d’immunothérapies anticancéreuses issue du génie québécois, et le CQDM sont fiers d'annoncer le lancement d'un projet de...
CQDM and Epitopea Fund the Development and Validation of CryptoMap™, a Platform Enabling the Development of RNA-based Immunotherapies
September 26, 2024 07:30 ET
|
Epitopea
MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapy company, and CQDM are proud to announce the launch of a collaborative research project between Epitopea...
Epitopea reçoit une subvention dans le cadre du programme Cancer Therapeutics d’Innovate UK
September 12, 2024 04:00 ET
|
Epitopea
CAMBRIDGE, Royaume-Uni et MONTRÉAL, 12 sept. 2024 (GLOBE NEWSWIRE) -- Epitopea, société transatlantique d’immunothérapies anticancéreuses qui met au point des produits d’immunothérapie à ARN...
Epitopea Awarded Grant from Innovate UK’s Cancer Therapeutics Programme
September 12, 2024 04:00 ET
|
Epitopea
CAMBRIDGE, United Kingdom and MONTREAL, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies,...
Midland and SOQUEM Identify on Nachicapau New High-Grade Mineralized Occurrences and Expand the Footprint of the Copper-Gold-Silver Hydrothermal System
August 22, 2024 07:30 ET
|
Midland Exploration Inc.
MONTREAL, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD), in partnership with SOQUEM Inc. (“SOQUEM”), is pleased to announce the discovery of new showings on the...
LeddarTech Announces Up to US$9.0 Million Financing and US$1.5 Million of Convertible Note Conversions Above Market at US$2.00 Per Share
August 19, 2024 08:00 ET
|
LeddarTech inc.
QUEBEC CITY, Canada, Aug. 19, 2024 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech” or the “Company”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive...